Join the 155,000+ IMP followers

Bayer News

Bayer to present real-world study data of Kerendia (finerenone)

Bayer will present data on Kerendia™ (finerenone) use among patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in real-world clinical practice, as well as new risk models for patients with CKD and T2D at the 61st European Renal Association (ERA) Congress.

Join the 155,000+ IMP followers

International